SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-017598
Filing Date
2009-02-03
Accepted
2009-02-03 16:31:03
Documents
4
Period of Report
2009-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17052
2 AMENDMENT NO. 1 TO THE NOTE AMENDMENT AND EXCHANGE AGREEMENT dex101.htm EX-10.1 135244
3 NEWS RELEASE dex991.htm EX-99.1 9510
4 GRAPHIC g83581ex991oscient.jpg GRAPHIC 7571
  Complete submission text file 0001193125-09-017598.txt   174337
Mailing Address 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10824 | Film No.: 09565322
SIC: 2834 Pharmaceutical Preparations